Antiarrhythmics. 2. Synthesis and antiarrhythmic activity of N-(piperidylalkyl)trifluoroethoxybenzamides.

doi:10.1021/jm00216a016

Paper

Antiarrhythmics. 2. Synthesis and antiarrhythmic activity of N-(piperidylalkyl)trifluoroethoxybenzamides.

Published Jun 1, 1977 · E. H. Banitt, W. Bronn, W. Coyne

Journal of medicinal chemistry

Q1 SJR score

57

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Benzamides characterized by one or more 2,2,2-trifluoroethoxy ring substituents and a heterocyclic amide side chain have been prepared and evaluated for oral antiarrhythmic activity in mice. The most potent compounds are derived from 2,5-bis(2,2,2-trifluoroethoxy)benzamide, and, within this group, both tertiary as well as secondary benzamides are active. Considerable variation in the heterocyclic ring is permissible, but antiarrhythmic activity is strongly influenced by the basicity of the amine nitrogen and the nature of the link between heterocycle and amide nitrogen. One of these compounds, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate (flecainide acetate, USAN), was studied extensively in animals and selected for clinical trial as an antiarrhythmic.

Study Snapshot

N-(piperidylalkyl)trifluoroethoxybenzamides show potent oral antiarrhythmic activity in mice, with potential for clinical trials.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Antiarrhythmics. 2. Synthesis and antiarrhythmic activity of N-(piperidylalkyl)trifluoroethoxybenzamides.

Sign up to use Study Snapshot

References

Citations

Ligand binding at the protein–lipid interface: strategic considerations for drug design

Ligand binding at the protein-lipid interface plays a larger role in small-molecule drug action than previously appreciated, impacting drug design and pharmacokinetics.

Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Translation of basic discoveries into safe and effective new treatments for atrial fibrillation is challenging, but a significant breakthrough could revolutionize both AF management and therapeutic development.

Mechanisms underlying pathological Ca2+ handling in diseases of the heart

Intracellular calcium signaling plays a crucial role in maintaining cardiac rhythm and contractility, and inherited or acquired defects in calcium channel subunits contribute to heart diseases.

RYR2 Channel Inhibition Is the Principal Mechanism 0f Flecainide Action in CPVT.

Flecainide's antiarrhythmic action in CPVT is primarily due to its ability to inhibit ryR2-mediated calcium release, rather than solely relying on sodium channel block.

Direct Phosphorus‐Induced Fluoroalkylthiolation with Fluoroalkylsulfonyl Chlorides

This method allows for efficient fluoroalkylthiolation of electron-rich arenes and thiols using diethyl phosphite as reducing agent, making it a practical and efficient method for electrophilic fluoroalkylthiolation.

The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Basic research insights into atrial fibrillation mechanisms can guide future therapeutic innovation, but challenges remain in translating these findings to clinical application.

Introduction of fluorine and fluorine-containing functional groups.

Modern fluorination methods have made fluorinated molecules more readily available and impact research areas like drug discovery and positron emission tomography, despite limitations in generality, predictability, and cost-efficiency.